Cesar A. Moran, M.D.

Peer-Reviewed Articles

1. Parra ER, Zhang J, Jiang M, Tamegnon A, Pandurengan RK, Behrens C, Solis L, Haymaker C, Heymach JV, Moran C, Lee JJ, Gibbons D, Wistuba II. Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer. Nat Commun 14(1):2364, 2023. e-Pub 2023. PMID: 37185575.
2. Perez YE, Moran CA. The thymus: General concepts on embryology, anatomy, histology and immunohistochemistry. Semin Diagn Pathol 39(2):86-91, 2022. e-Pub 2021. PMID: 34147301.
3. Oramas DM, Moran CA. Thymoma: Histologically a heterogenous group of tumors. Semin Diagn Pathol 39(2):99-104, 2022. e-Pub 2021. PMID: 34147302.
4. Moran CA. Mediastinal pathology: A global approach of clinical, radiological, and histological assessment. Semin Diagn Pathol 39(2):85, 2022. e-Pub 2021. PMID: 34284923.
5. Oramas DM, Moran CA. Multilocular thymic cyst (MTC) and other tumors with MTC features: Pitfalls in diagnosis. Semin Diagn Pathol 39(2):105-112, 2022. e-Pub 2021. PMID: 34147305.
6. Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D'Amico TA, D'Avella C, Dowlati A, Downey RJ, Edelman M, Florsheim C, Gold KA, Goldman JW, Grecula JC, Hann C, Iams W, Iyengar P, Kelly K, Khalil M, Koczywas M, Merritt RE, Mohindra N, Molina J, Moran CA, Pokharel S, Puri S, Qin A, Rusthoven C, Sands J, Santana-Davila R, Shafique M, Waqar SN, Gregory KM, Hughes M. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(12):1441-1464, 2021. PMID: 34902832.
7. Tang M, Abbas HA, Negrao MV, Ramineni M, Hu X, Hubert SM, Fujimoto J, Reuben A, Varghese S, Zhang J, Li J, Chow CW, Mao X, Song X, Lee WC, Wu J, Little L, Gumbs C, Behrens C, Moran CA, Weissferdt A, Lee JJ, Sepesi B, Swisher S, Cheng C, Kurie J, Gibbons D, Heymach JV, Wistuba II, Futreal PA, Kalhor N, Zhang J. The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics. Nat Commun 12(1):7081, 2021. e-Pub 2021. PMID: 34873156.
8. Oramas DM, Zaleski M, Moran CA. Sarcomatoid Mesothelioma: A Clinicopathological and Immunohistochemical Study of 64 Cases. Int J Surg Pathol 29(8):820-825, 2021. e-Pub 2021. PMID: 33939493.
9. Alqaidy D, Moran CA. Primary Warthin's-like adenocarcinoma of the lung: A clinicopathological, immunohistochemical, and molecular analysis of three cases. Pathol Res Pract 227:153648, 2021. e-Pub 2021. PMID: 34656914.
10. Moran CA. Mediastinal Pathology. Adv Anat Pathol 28(5):289-290, 2021. PMID: 34294658.
11. Moran CA. Thymoma Staging: An Analysis of the Different Schemas. Adv Anat Pathol 28(5):298-306, 2021. PMID: 34326287.
12. Oramas DM, Moran CA. Primary Giant Cell Tumors of the Lung: A Clinicopathologic and Immunohistochemical Study of 3 Cases. Am J Surg Pathol 45(8):1151-1154, 2021. PMID: 33560658.
13. Rocha P, Salazar R, Zhang J, Ledesma D, Solorzano JL, Mino B, Villalobos P, Dejima H, Douse DY, Diao L, Mitchell KG, Le X, Zhang J, Weissferdt A, Parra-Cuentas E, Cascone T, Rice DC, Sepesi B, Kalhor N, Moran CA, Vaporciyan A, Heymach J, Gibbons DL, Lee JJ, Kadara H, Wistuba I, Behrens C, Solis LM. CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma. Cancer Immunol Immunother 70(7):1965-1976, 2021. e-Pub 2021. PMID: 33416944.
14. Rocha P, Salazar R, Zhang J, Ledesma D, Solorzano JL, Mino B, Villalobos P, Dejima H, Douse DY, Diao L, Mitchell KG, Le X, Zhang J, Weissferdt A, Parra-Cuentas E, Cascone T, Rice DC, Sepesi B, Kalhor N, Moran CA, Vaporciyan A, Heymach J, Gibbons DL, Lee JJ, Kadara H, Wistuba I, Behrens C, Solis LM. Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma. Cancer Immunol Immunother 70(7):1977-1978, 2021. PMID: 33686493.
15. Zaleski M, Kalhor N, Moran CA. Typical and Atypical Carcinoid Tumors of the Mediastinum: A Biomarker Analysis of 27 Cases With Clinical Correlation. Int J Surg Pathol 29(4):358-367, 2021. e-Pub 2020. PMID: 33243039.
16. Behrens C, Rocha P, Parra ER, Feng L, Rodriguez-Canales J, Solis LM, Mino B, Zhang J, Gibbons DL, Sepesi B, Rice D, Heymach JV, Moran CA, Creighton CJ, Lee JJ, Kadara H, Wistuba II. Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma. Clin Lung Cancer 22(3):e415-e424, 2021. e-Pub 2020. PMID: 32763065.
17. Oramas DM, Alqaidy D, Moran CA. Primary pulmonary hyalinizing spindle cell tumor with giant rosettes: A clinicopathological and immunohistochemical study of 2 cases. Ann Diagn Pathol 51:151706, 2021. e-Pub 2021. PMID: 33516059.
18. Oramas DM, Moran CA. Major Pathologic Response in Patients Treated for Non-small Cell Carcinoma of the Lung: Is There a Magic Number in the Histologic Sections to Be Evaluated?. Adv Anat Pathol 28(2):67-71, 2021. PMID: 33405399.
19. Liu X, Wang F, Xu C, Chen X, Hou X, Li Q, Li P, Xie Z, Liu Y, Chang L, Guan Y, Zhang X, Yang L, Wang H, Yi X, Zhang J, Xia X, Moran CA, Chen L. Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma. Oncogene 40(4):821-832, 2021. e-Pub 2020. PMID: 33273725.
20. Zaleski M, Kalhor N, Fujimoto J, Wistuba I, Moran CA. Sarcomatoid Mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with BAP1. Pathol Res Pract 216(12):153267, 2020. e-Pub 2020. PMID: 33176261.
21. Zaleski MP, Kalhor N, Moran CA. Mucous Gland Adenoma: The Spectrum of Growth Patterns and the Diagnostic Challenges. Adv Anat Pathol 27(6):371-379, 2020. PMID: 32909967.
22. Oramas DM, Moran CA. Micronodular Thymomas With Prominent Cystic Changes: A Clinicopathological and Immunohistochemical Study of 25 Cases. Int J Surg Pathol:1066896920963803. e-Pub 2020. PMID: 33026263.
23. Mitchell KG, Parra ER, Zhang J, Nelson DB, Corsini EM, Villalobos P, Moran CA, Skoulidis F, Wistuba II, Fujimoto J, Roth JA, Antonoff MB, MD Anderson Lung Cancer Immune Microenvironment Working Group. LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of Recurrence. Ann Thorac Surg 110(4):1131-1138, 2020. e-Pub 2020. PMID: 32442617.
24. Lindholm KE, Moran CA. Primary Mammary-Like Carcinoma of the Lung: A Case Report of a Distinct Type of Primary Lung Carcinoma. Int J Surg Pathol 28(6):663-667, 2020. e-Pub 2020. PMID: 32050837.
25. Mitchell KG, Amini B, Wang Y, Carter BW, Godoy MCB, Parra ER, Behrens C, Villalobos P, Reuben A, Lee JJ, Weissferdt A, Moran CA, Fujimoto J, Sepesi B, Walsh GL, Vaporciyan AA, Hofstetter WL, William WN, Gibbons DL, Wang J, Hwu P, Swisher SG, Piwnica-Worms D, Kadara H, Wistuba II, Heymach JV, Peng W, Cascone T. 18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer. Cancer Immunol Immunother 69(8):1519-1534, 2020. e-Pub 2020. PMID: 32300858.
26. Lindholm KE, Sansano-Valero I, Rodriguez JL, Ramon Y Cajal S, Moran CA. Pulmonary Adenofibromas: A Clinicopathologic Correlation of 13 Cases. Am J Surg Pathol 44(7):917-921, 2020. PMID: 32091433.
27. Weissferdt A, Pataer A, Vaporciyan AA, Correa AM, Sepesi B, Moran CA, Wistuba II, Roth JA, Shewale JB, Heymach JV, Kalhor N, Cascone T, Hofstetter WL, Lee JJ, Swisher SG. Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy. Clin Lung Cancer 21(4):341-348, 2020. e-Pub 2020. PMID: 32279936.
28. Cascone T, Sepesi B, Lin HY, Kalhor N, Parra ER, Jiang M, Godoy MCB, Zhang J, Fossella FV, Tsao AS, Lam VK, Lu C, Mott FE, Simon GR, Antonoff MB, Mehran RJ, Rice DC, Behrens C, Weissferdt A, Moran CA, Vaporciyan AA, Lee JJ, Swisher SG, Gibbons DL, Wistuba II, William WN, Heymach JV. A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer. Clin Cancer Res 26(14):3525-3536, 2020. e-Pub 2020. PMID: 32193228.
29. Lindholm KE, Moran CA. Hemangioblastoma-like Clear Cell Stromal Tumor of the Lung: A Clinicopathologic and Immunohistochemical Study of 5 Cases. Am J Surg Pathol 44(6):771-775, 2020. PMID: 31913155.
30. Thomas A, Mian I, Tlemsani C, Pongor L, Takahashi N, Maignan K, Snider J, Li G, Frampton G, Ali S, Kim S, Nichols S, Rajapakse V, Guha U, Sharon E, Fujimoto J, Moran CA, Wistuba II, Wei JS, Khan J, Szabo E, Torres AZ, Carson KR. Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study. Chest. e-Pub 2020. PMID: 32464188.
31. Moran CA, Lindholm KE, Brunnström H, Langman G, Jang SJ, Spagnolo D, Chai SM, Laycock A, Falconieri G, Pizzolitto S, de Pellegrin A, Medeiros F, Edmunds L, Catarino A, Cunha F, Ro J, Pina-Oviedo S, Torrealba J, Coppola D, Petersson F, Oon ML, Elmberger G, Y Cajal SR, Valero IS, Dalurzo L, Soares F, Campos AH, Vranic S, Skenderi F, Correa AM, Sepesi B, Rice D, Mehran R, Walsh G. Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features. Hum Pathol 98:98-109, 2020. e-Pub 2020. PMID: 32145220.
32. Stewart CA, Gay CM, Xi Y, Sivajothi S, Sivakamasundari V, Fujimoto J, Bolisetty M, Hartsfield PM, Balasubramaniyan V, Chalishazar MD, Moran CA, Kalhor N, Stewart J, Tran H, Swisher SG, Roth JA, Zhang J, de Groot J, Glisson B, Oliver TG, Heymach JV, Wistuba I, Robson P, Wang J, Byers LA. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Nat Cancer 1:423-436, 2020. e-Pub 2020. PMID: 33521652.
33. Nelson DB, Mitchell KG, Wang J, Fujimoto J, Godoy M, Behrens C, Zheng X, Zhang J, Sepesi B, Vaporciyan AA, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Swisher SG,Moran CA, Kalhor N, Weissferdt A, Wistuba II, Roth JA, Antonoff MB. Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities. J Thorac Dis 12(3):329-337, 2020. PMID: 32274099.
34. Zaleski MP, Truong M, Moran CA. Primary mediastinal chondrosarcomas: do they really exist?. Mediastinum 4:24, 2020. e-Pub 2020. PMID: 35118292.
35. Dawood W, La Garza Henriette , Iliescu G, Moran CA, Grosu H. Pleural tuberculosis mimicking malignant mesothelioma. Respir Med Case Rep 29:100964, 2020. e-Pub 2019. PMID: 31768308.
36. Reuben A, Zhang J, Chiou SH, Gittelman RM, Li J, Lee WC, Fujimoto J, Behrens C, Liu X, Wang F, Quek K, Wang C, Kheradmand F, Chen R, Chow CW, Lin H, Bernatchez C, Jalali A, Hu X, Wu CJ, Eterovic AK, Parra ER, Yusko E, Emerson R, Benzeno S, Vignali M, Wu X, Ye Y, Little LD, Gumbs C, Mao X, Song X, Tippen S, Thornton RL, Cascone T, Snyder A, Wargo JA, Herbst R, Swisher S, Kadara H, Moran CA, Kalhor N, Zhang J, Scheet P, Vaporciyan AA, Sepesi B, Gibbons DL, Robins H, Hwu P, Heymach JV, Sharma P, Allison JP, Baladandayuthapani V, Lee JJ, Davis MM, Wistuba II, Futreal PA, Zhang J. Comprehensive T cell repertoire characterization of non-small cell lung cancer. Nat Commun 11(1):603, 2020. e-Pub 2020. PMID: 32001676.
37. Yenerall P, Das AK, Wang S, Kollipara RK, Li LS, Villalobos P, Flaming J, Lin YF, Huffman K, Timmons BC, Gilbreath C, Sonavane R, Kinch LN, Rodriguez-Canales J,Moran CA, Behrens C, Hirasawa M, Takata T, Murakami R, Iwanaga K, Chen BPC, Grishin NV, Raj GV, Wistuba II, Minna JD, Kittler R. RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer. Cell Chem Biol 27(1):105-121.e14, 2020. e-Pub 2019. PMID: 31883965.
38. Suster S, Moran CA. Editorial: "Evidence Based Pathology". Ann Diagn Pathol 43:151435, 2019. e-Pub 2019. PMID: 31848045.
39. Wang S, Wang T, Yang L, Yang DM, Fujimoto J, Yi F, Luo X, Yang Y, Yao B, Lin S,Moran CA, Kalhor N, Weissferdt A, Minna J, Xie Y, Wistuba II, Mao Y, Xiao G. ConvPath: A software tool for lung adenocarcinoma digital pathological image analysis aided by a convolutional neural network. EBioMedicine 50:103-110, 2019. e-Pub 2019. PMID: 31767541.
40. Piña-Oviedo S, Moran CA. Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 1. Adv Anat Pathol 26(6):346-370, 2019. PMID: 31567132.
41. Piña-Oviedo S, Moran CA. Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 2. Adv Anat Pathol 26(6):371-389, 2019. PMID: 31567129.
42. Kadara H, Sivakumar S, Jakubek Y, San Lucas FA, Lang W, McDowell T, Weber Z, Behrens C, Davies GE, Kalhor N, Moran CA, El-Zein R, Mehran R, Swisher SG, Wang J, Zhang J, Fujimoto J, Fowler J, Heymach JV, Dubinett S, Spira AE, Ehli EA, Wistuba II, Scheet P. Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer. Am J Respir Crit Care Med 200(6):742-750, 2019. PMID: 30896962.
43. Monroig-Bosque PDC, Morales-Rosado JA, Roden AC, Churg A, Barrios R, Cagle P, Ge Y, Allen TC, Smith ML, Larsen BT, Sholl LM, Beasley MB, Borczuk A, Raparia K, Ayala A, Tazelaar HD, Miller R, Kalhor N, Moran CA, Ro JY. Micropapillary adenocarcinoma of lung: Morphological criteria and diagnostic reproducibility among pulmonary pathologists. Ann Diagn Pathol 41:43-50, 2019. e-Pub 2019. PMID: 31132651.
44. Lindholm KE, de Groot P, Moran CA. Fibrosing/Sclerosing Lesions of the Mediastinum: A Review. Adv Anat Pathol 26(4):235-240, 2019. PMID: 30608259.
45. Lindholm KE, Moran CA. Xanthomatous Thymoma: A Clinicopathologic and Immunohistochemical Study of 10 Cases. Am J Clin Pathol 151(6):593-597, 2019. PMID: 30816919.
46. Luo X, Yin S, Yang L, Fujimoto J, Yang Y, Moran CA, Kalhor N, Weissferdt A, Xie Y, Gazdar A, Minna J, Wistuba II, Mao Y, Xiao G. Development and Validation of a Pathology Image Analysis-based Predictive Model for Lung Adenocarcinoma Prognosis - A Multi-cohort Study. Sci Rep 9(1):6886, 2019. e-Pub 2019. PMID: 31053738.
47. Kalhor N, Moran CA. Thymic epithelial neoplasms with sebaceous differentiation: a clinicopathological and immunohistochemical study of 8 cases. Hum Pathol 86:124-128, 2019. e-Pub 2018. PMID: 30537491.
48. Lindholm KE, Kalhor N, Moran CA. Osteoclast-like giant cell-rich carcinomas of the lung: a clinicopathological, immunohistochemical, and molecular study of 3 cases. Hum Pathol 85:168-173, 2019. e-Pub 2018. PMID: 30447297.
49. Kalhor N, Moran CA. Thymic epithelial neoplasms with rhabdomyomatous component: a clinicopathological and immunohistochemical study of 7 cases. Hum Pathol 83:100-105, 2019. e-Pub 2018. PMID: 30217623.
50. Kalhor N, Moran CA. Thymomas With a Prominent Alveolar Growth Pattern: A Clinicopathologic and Immunohistochemical Study of 12 Cases. Am J Clin Pathol 151(2):171-175, 2019. PMID: 30247496.
51. Xie Y, Lu W, Wang S, Tang X, Tang H, Zhou Y, Moran CA, Behrens C, Roth JA, Zhou Q, Johnson DH, Swisher SG, Heymach JV, Papadimitrakopoulou VA, Xiao G, Minna JD, Wistuba II. Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer. Clin Cancer Res 25(1):150-157, 2019. e-Pub 2018. PMID: 30287547.
52. Deribe YL, Sun Y, Terranova C, Khan F, Martinez-Ledesma J, Gay J, Gao G, Mullinax RA, Khor T, Feng N, Lin YH, Wu CC, Reyes C, Peng Q, Robinson F, Inoue A, Kochat V, Liu CG, Asara JM, Moran CA, Muller F, Wang J, Fang B, Papadimitrakopoulou V, Wistuba II, Rai K, Marszalek J, Futreal PA. Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nat Med 24(10):1627, 2018. PMID: 30104769.
53. Kalemkerian GP, Loo BW, Akerley W, Attia A, Bassetti M, Boumber Y, Decker R, Dobelbower MC, Dowlati A, Downey RJ, Florsheim C, Ganti AKP, Grecula JC, Gubens MA, Hann CL, Hayman JA, Heist RS, Koczywas M, Merritt RE, Mohindra N, Molina J, Moran CA, Morgensztern D, Pokharel S, Portnoy DC, Rhodes D, Rusthoven C, Sands J, Santana-Davila R, Williams CC, Hoffmann KG, Hughes M. NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018. J Natl Compr Canc Netw 16(10):1171-1182, 2018. PMID: 30323087.
54. Moran CA, Suster S. Reprint of: Unusual non-neoplastic lesions of the lung. Semin Diagn Pathol 35(5):339-346, 2018. e-Pub 2018. PMID: 30249369.
55. Aldana G, Jimenez CA, Moran CA. Unusual cause of sinusitis and cough. BMJ Case Rep 2018, 2018. e-Pub 2018. PMID: 30030254.
56. Lissanu Deribe Y, Sun Y, Terranova C, Khan F, Martinez-Ledesma J, Gay J, Gao G, Mullinax RA, Khor T, Feng N, Lin YH, Wu CC, Reyes C, Peng Q, Robinson F, Inoue A, Kochat V, Liu CG, Asara JM, Moran CA, Muller F, Wang J, Fang B, Papadimitrakopoulou V, Wistuba II, Rai K, Marszalek J, Futreal PA. Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nat Med 24(7):1047-1057, 2018. e-Pub 2018. PMID: 29892061.
57. Parra ER, Villalobos P, Behrens C, Jiang M, Pataer A, Swisher SG, William WN, Zhang J, Lee J, Cascone T, Heymach JV, Forget MA, Haymaker C, Bernatchez C, Kalhor N, Weissferdt A, Moran CA, Zhang J, Vaporciyan A, Gibbons DL, Sepesi B, Wistuba II. Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. J Immunother Cancer 6(1):48, 2018. e-Pub 2018. PMID: 29871672.
58. de Groot PM, Shroff GS, Ahrar J, Sabloff BS, Gladish GM, Moran CA Gupta S, Gladish GW, Chang JY, Erasmus JJ. Implications for high-precision dose radiation therapy planning or limited surgical resection after percutaneous computed tomography-guided lung nodule biopsy using a tract sealant. Adv Radiat Oncol 3(2):139-145, 2018. e-Pub 2017. PMID: 29904738.
59. Parra ER, Villalobos P, Zhang J, Behrens C, Mino B, Swisher S, Sepesi B, Weissferdt A, Kalhor N, Heymach JV, Moran CA, Zhang J, Lee J, Rodriguez-Canales J, Gibbons D, Wistuba II. Immunohistochemical and Image Analysis-based Study Demonstrate that Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors. J Thorac Oncol. e-Pub 2018. PMID: 29526824.
60. Weissferdt A, Kalhor N, Bishop JA, Jang SJ, Ro J, Petersson F, Wu B, Langman G, Bancroft H, Bi Y, Meng Y, Medeiros F, Brunnstrom H, Spagnolo D, Chai SM, Laycock A, Wakely PE, Elmberger G, Soares FA, Campos AH, Gumurdulu D, Alvarado-Cabrero I, Coppola D, Correa AM, Rice D, Mehran RJ, Sepesi B, Walsh G, Kaiser L, Moran CA. Thymoma: a clinicopathological correlation of 1470 cases. Hum Pathol 73:7-15, 2018. e-Pub 2017. PMID: 28851660.
61. Kalhor N, Moran CA. Pulmonary mucoepidermoid carcinoma: diagnosis and treatment. Expert Rev Respir Med 12(3):249-255, 2018. e-Pub 2018. PMID: 29338644.
62. Lee WC, Diao L, Wang J, Zhang J, Roarty EB, Varghese S, Chow CW, Fujimoto J, Behrens C, Cascone T, Peng W, Kalhor N, Moran CA, Weissferdt A, Johnson FM, William WN, Swisher SG, Lee JJ, Hong WK, Heymach JV, Wistuba II, Futreal PA, Zhang J. Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer. Mod Pathol. e-Pub 2018. PMID: 29410488.
63. Weissferdt A, Kalhor N, Moran CA. Cutaneous basal cell carcinoma with distant metastasis to thorax and bone : A clinicopathological and immunohistochemical study of 15 cases. Virchows Arch. e-Pub 2017. PMID: 28391557.
64. Weissferdt A, Fujimoto J, Kalhor N, Rodriguez J, Bassett R, Wistuba II, Moran CA. Expression of PD-1 and PD-L1 in thymic epithelial neoplasms. Mod Pathol. e-Pub 2017. PMID: 28281549.
65. Salem A, Bell D, Sepesi B, Papadimitrakopoulou V, El-Naggar A, Moran CA, Kalhor N. Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature. Virchows Arch. e-Pub 2017. PMID: 28343305.
66. Weissferdt A, Kalhor N, Rodriguez Canales J, Fujimoto J, Wistuba II, Moran CA. Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases. Hum Pathol 59:1-9, 2017. e-Pub 2016. PMID: 27569293.
67. Kadara H, Choi M, Zhang J, Parra ER, Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Yoo Y, Kalhor N, Moran CA, Rimm D, Swisher S, Gibbons DL, Heymach J, Kaftan E, Townsend JP, Lynch TJ, Schlessinger J, Lee J, Lifton RP, Wistuba II, Herbst RS. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up. Ann Oncol 28(1):75-82, 2017. e-Pub 2016. PMID: 27687306.
68. Kalhor N, Weissferdt A, Moran CA. Primary Salivary Gland Type Tumors of the Thymus. Adv Anat Pathol 24(1):15-23, 2017. PMID: 27941539.
69. Choi M, Kadara H, Zhang J, Parra ER, Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Kim K, Kalhor N, Moran CA, Rimm D, Swisher S, Gibbons DL, Heymach J, Kaftan E, Townsend JP, Lynch TJ, Schlessinger J, Lee J, Lifton RP, Herbst RS, Wistuba II. Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function. Ann Oncol 28(1):83-89, 2017. PMID: 28177435.
70. Parra ER, Behrens C, Rodriguez-Canales J, Lin H, Mino B, Blando J, Zhang J, Gibbons DL, Heymach JV, Sepesi B, Swisher SG, Weissferdt A, Kalhor N, Izzo J, Kadara H, Moran CA, Lee JJ, Wistuba II. Image Analysis-Based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-Small Cell Lung Carcinoma Patients. Clin Cancer Res 22(24):6278-6289, 2016. e-Pub 2016. PMID: 27252415.
71. Weissferdt A, Kalhor N, Correa AM, Moran CA. "Sarcomatoid" carcinomas of the lung: a clinicopathologic study of 86 cases with a new perspective on tumor classification. Hum Pathol. e-Pub 2016. PMID: 27993578.
72. Weissferdt A, Kalhor N, Moran CA. Pleuromediastinal Epithelial-Myoepithelial Carcinomas: A Clinicopathologic and Immunohistochemical Study of Two Cases. Am J Clin Pathol 146(6):736-740, 2016. e-Pub 2016. PMID: 27864182.
73. Weissferdt A, Kalhor N, Petersson F, Moran CA. Ectopic Hamartomatous Thymoma-New Insights Into a Challenging Entity: A Clinicopathologic and Immunohistochemical Study of 9 Cases. Am J Surg Pathol 40(11):1571-1576, 2016. PMID: 27428736.
74. Weissferdt A, Kalhor N, Moran CA. Sebaceous lymphadenoma of the thymus: A clinicopathologic and immunohistochemical study of 2 cases. Hum Pathol 56:189-93, 2016. e-Pub 2016. PMID: 27374279.
75. Weissferdt A, Kalhor N, Moran CA. Intrathoracic glomus tumors and glomangiosarcomas: a clinicopathological and immunohistochemical study of 14 cases with emphasis on anatomic distribution. Virchows Arch. e-Pub 2016. PMID: 27591766.
76. Weissferdt A, Kalhor N, Rodriguez Canales J, Fujimoto J, Wistuba II, Moran CA. Primary Mediastinal Yolk Sac Tumors: An Immunohistochemical Analysis of 14 Cases. Appl Immunohistochem Mol Morphol. e-Pub 2016. PMID: 27643524.
77. Piña-Oviedo S, Moran CA. Primary Mediastinal Classical Hodgkin Lymphoma. Adv Anat Pathol. e-Pub 2016. PMID: 27441757.
78. Weissferdt A, Kalhor N, Moran CA. Thymomas With Extensive Clear Cell Component: A Clinicopathologic and Immunohistochemical Study of Nine Cases. Am J Clin Pathol 146(1):132-6, 2016. e-Pub 2016. PMID: 27371363.
79. Jakubek Y, Lang W, Vattathil S, Garcia M, Xu L, Huang L, Yoo SY, Shen L, Lu W, Chow CW, Weber Z, Davies G, Huang J, Behrens C, Kalhor N, Moran CA, Fujimoto J, Mehran R, El-Zein R, Swisher SG, Wang J, Fowler J, Spira AE, Ehli EA, Wistuba II, Scheet P, Kadara H. Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway. Cancer Res 76(13):3676-83, 2016. e-Pub 2016. PMID: 27216194.
80. Goh GH, Teh M, Vanecek T, Moran CA, Petersson F. Primary pulmonary clear cell sarcoma-the first two reported cases. Virchows Arch 469(1):111-7, 2016. e-Pub 2016. PMID: 27112339.
81. Weissferdt A, Moran CA. The spectrum of ectopic thymomas. Virchows Arch. e-Pub 2016. PMID: 27255665.
82. Weissferdt A, Moran CA. Primary giant cell carcinomas of the lung: a clinicopathological and immunohistochemical analysis of seven cases. Histopathology 68(5):680-5, 2016. e-Pub 2015. PMID: 26259572.
83. Weissferdt A, Moran CA. Ectopic primary intrathyroidal thymoma: a clinicopathological and immunohistochemical analysis of 3 cases. Hum Pathol 49:71-6, 2016. e-Pub 2015. PMID: 26826412.
84. Weissferdt A, Moran CA. Neuroendocrine Differentiation in Thymic Carcinomas: A Diagnostic Pitfall: An Immunohistochemical Analysis of 27 Cases. Am J Clin Pathol 145(3):393-400, 2016. e-Pub 2016. PMID: 27124922.
85. Weissferdt A, Kalhor N, Moran CA. Cystic well-differentiated squamous cell carcinoma of the thymus: a clinicopathological and immunohistochemical study of six cases. Histopathology 68(3):333-8, 2016. e-Pub 2015. PMID: 26031186.
86. Riquelme E, Behrens C, Lin HY, Simon G, Papadimitrakopoulou V, Izzo J, Moran CA, Kalhor N, Lee JJ, Minna JD, Wistuba II. Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations. Cancer Res 76(3):675-85, 2016. e-Pub 2015. PMID: 26676756.
87. Falk N, Weissferdt A, Kalhor N, Moran CA. Primary Pulmonary Salivary Gland-type Tumors: A Review and Update. Adv Anat Pathol 23(1):13-23, 2016. PMID: 26645458.
88. Weissferdt A, Tang X, Suster S, Wistuba II, Moran CA. Pleuropulmonary Meningothelial Proliferations: Evidence for a Common Histogenesis. Am J Surg Pathol 39(12):1673-8, 2015. PMID: 26291511.
89. Piña-Oviedo S, Weissferdt A, Kalhor N, Moran CA. Primary Pulmonary Lymphomas. Adv Anat Pathol 22(6):355-75, 2015. PMID: 26452211.
90. Weissferdt A, Kalhor N, Moran CA. Primary thymic cholesteroloma: a clinicopathological correlation of four cases of an unusual benign lesion. Virchows Arch 467(5):609-11, 2015. e-Pub 2015. PMID: 26266777.
91. Zenali MJ, Weissferdt A, Solis LM, Ali S, Tang X, Mehran RJ, Wistuba II, Moran CA, Kalhor N. An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung. Hum Pathol 46(6):836-42, 2015. e-Pub 2015. PMID: 25776025.
92. Weissferdt A, Kalhor N, Moran CA. Ewing sarcoma with extensive neural differentiation: a clinicopathologic, immunohistochemical, and molecular analysis of three cases. Am J Clin Pathol 143(5):659-64, 2015. PMID: 25873499.
93. Hu S, Danilov AV, Godek K, Orr B, Tafe LJ, Rodriguez-Canales J, Behrens C, Mino B, Moran CA, Memoli VA, Mustachio LM, Galimberti F, Ravi S, DeCastro A, Lu Y, Sekula D, Andrew AS, Wistuba II, Freemantle S, Compton DA, Dmitrovsky E. CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110. Cancer Res 75(10):2029-38, 2015. e-Pub 2015. PMID: 25808870.
94. Ortega P, Suster D, Falconieri G, Zambrano E, Moran CA, Morrison C, Suster S. Liposarcomas of the posterior mediastinum: clinicopathologic study of 18 cases. Mod Pathol 28(5):721-31, 2015. e-Pub 2014. PMID: 25475695.
95. Weissferdt A, Rodriguez-Canales J, Liu H, Fujimoto J, Wistuba II, Moran CA. Primary mediastinal seminomas: a comprehensive immunohistochemical study with a focus on novel markers. Hum Pathol 46(3):376-83, 2015. e-Pub 2014. PMID: 25576290.
96. Weissferdt A, Moran CA. Mediastinal seminoma with florid follicular lymphoid hyperplasia: a clinicopathological and immunohistochemical study of six cases. Virchows Arch 466(2):209-15, 2015. e-Pub 2014. PMID: 25425477.
97. Weissferdt A, Moran CA. Staging of thymic epithelial neoplasms: thymoma and thymic carcinoma. Pathol Res Pract 211(1):2-11, 2015. e-Pub 2014. PMID: 25441660.
98. Weissferdt A, Kalhor N, Liu H, Rodriguez J, Fujimoto J, Tang X, Wistuba II, Moran CAA. Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases. Hum Pathol 45(12):2463-70, 2014. e-Pub 2014. PMID: 25294372.
99. Weissferdt A, Kalhor N, Moran CA. Combined thymoma-thymic seminoma. Report of 2 cases of a heretofore unreported association. Hum Pathol 45(10):2168-72, 2014. e-Pub 2014. PMID: 25090916.
100. Zhang J, Fujimoto J, Zhang J, Wedge DC, Song X, Zhang J, Seth S, Chow CW, Cao Y, Gumbs C, Gold KA, Kalhor N, Little L, Mahadeshwar H, Moran CA, Protopopov A, Sun H, Tang J, Wu X, Ye Y, William WN, Lee JJ, Heymach JV, Hong WK, Swisher S, Wistuba II, Futreal PA. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346(6206):256-9, 2014. PMID: 25301631.
101. Weissferdt A, Moran CA. Spindle cell thymomas with neuroendocrine morphology: a clinicopathological and immunohistochemical study of 18 cases. Histopathology 65(1):111-8, 2014. e-Pub 2014. PMID: 24702597.
102. Weissferdt A, Moran CA. Epithelioid hemangioendothelioma of the bone: a review and update. Adv Anat Pathol 21(4):254-9, 2014. PMID: 24911250.
103. Weissferdt A, Kalhor N, Moran CA. Lung carcinoma: Beyond the WHO classification. Semin Diagn Pathol 31(4):259, 2014. e-Pub 2014. PMID: 25002355.
104. Weissferdt A, Walsh G, Kaiser L, Moran CA. Pulmonary adenocarcinoma T1N0M0 and its classification. Semin Diagn Pathol 31(4):260-4, 2014. e-Pub 2014. PMID: 25012478.
105. Weissferdt A, Moran CA. Immunohistochemistry in the Diagnosis of Thymic Epithelial Neoplasms. Appl Immunohistochem Mol Morphol. e-Pub 2014. PMID: 24897066.
106. Tsao AS, Harun N, Fujimoto J, Devito V, Lee JJ, Kuhn E, Mehran R, Rice D, Moran CA, Hong WK, Shen L, Suraokar M, Wistuba I. Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma. Ann Diagn Pathol 18(3):140-5, 2014. e-Pub 2014. PMID: 24747001.
107. Weissferdt A, Moran CA. Lipomatous tumors of the anterior mediastinum with muscle differentiation: a clinicopathological and immunohistochemical study of three cases. Virchows Arch 464(4):489-93, 2014. e-Pub 2014. PMID: 24558031.
108. Weissferdt A, Moran CA. The histomorphologic spectrum of spindle cell thymoma. Hum Pathol pii: S0046-8177((12)00328-0):doi: 10.1, 2014. e-Pub 2012. PMID: 23260329.
109. Kadara H, Fujimoto J, Yoo SY, Maki Y, Gower AC, Kabbout M, Garcia MM, Chow CW, Chu Z, Mendoza G, Shen L, Kalhor N, Hong WK, Moran CA, Wang J, Spira A, Coombes KR, Wistuba II. Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer. J Natl Cancer Inst 106(3):dju004, 2014. e-Pub 2014. PMID: 24563515.
110. Detterbeck FC, Moran CA, Huang J, Suster S, Walsh G, Kaiser L, Wick M. [Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy]. Zhongguo Fei Ai Za Zhi 17(2):95-103, 2014. PMID: 24581159.
111. Detterbeck FC, Nicholson AG, Kondo K, Van Schil P, Moran CA. [The Masaoka-Koga stage classification for thymic malignancies clarification and definition of terms]. Zhongguo Fei Ai Za Zhi 17(2):75-81, 2014. PMID: 24581156.
112. Weissferdt A, Phan A, Suster S, Moran CA. Adrenocortical Carcinoma: A Comprehensive Immunohistochemical Study of 40 Cases. Appl Immunohistochem Mol Morphol 22(1):24-30, 2014. e-Pub 2013. PMID: 23531850.
113. Weissferdt A, Tang X, Wistuba II, Moran CA. Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1. Mod Pathol 26(12):1554-60, 2013. e-Pub 2013. PMID: 23787439.
114. Behrens C, Solis LM, Lin H, Yuan P, Tang X, Kadara H, Riquelme E, Galindo H, Moran CA, Kalhor N, Swisher SG, Simon GR, Stewart DJ, Lee JJ, Wistuba II. EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma. Clin Cancer Res 19(23):6556-65, 2013. e-Pub 2013. PMID: 24097870.
115. Wistuba II, Behrens C, Lombardi F, Wagner S, Fujimoto J, Raso MG, Spaggiari L, Galetta D, Riley R, Hughes E, Reid J, Sangale Z, Swisher SG, Kalhor N, Moran CA, Gutin A, Lanchbury JS, Barberis M, Kim ES. Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma. Clin Cancer Res 19(22):6261-71, 2013. e-Pub 2013. PMID: 24048333.
116. Weissferdt A, Kalhor N, Moran CA. Well-differentiated adenocarcinoma-bronchioloalveolar carcinoma-in situ adenocarcinoma: a conundrum. Adv Anat Pathol 20(5):347-51, 2013. PMID: 23939151.
117. Weissferdt A, Moran CA. Thymomas with prominent glandular differentiation: a clinicopathologic and immunohistochemical study of 12 cases. Hum Pathol 44(8):1612-6, 2013. e-Pub 2013. PMID: 23528863.
118. Weissferdt A, Kalhor N, Marom EM, Benveniste MF, Godoy MC, Correa AM, Swisher SG, Moran CA. Early-stage pulmonary adenocarcinoma (T1N0M0): a clinical, radiological, surgical, and pathological correlation of 104 cases. The MD Anderson Cancer Center Experience. Mod Pathol 26(8):1065-75, 2013. e-Pub 2013. PMID: 23542459.
119. Weissferdt A, Moran CA. The impact of neoadjuvant chemotherapy on the histopathological assessment of thymomas: a clinicopathological correlation of 28 cases treated with a similar regimen. Lung 191(4):379-83, 2013. e-Pub 2013. PMID: 23652348.
120. Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM. Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome. AJR Am J Roentgenol 201(1):W57-63, 2013. PMID: 23789697.
121. Weissferdt A, Phan A, Suster S, Moran CA. Myxoid adrenocortical carcinoma: a clinicopathologic and immunohistochemical study of 7 cases, including 1 case with lipomatous metaplasia. Am J Clin Pathol 139(6):780-6, 2013. PMID: 23690121.
122. Weissferdt A, Moran CA. Desmoplastic spindle cell thymomas: a clinicopathologic and immunohistochemical study of 14 cases. Hum Pathol 44(4):623-7, 2013. e-Pub 2012. PMID: 23084585.
123. Weissferdt A, Phan A, Suster S, Moran CA. Primary rhabdoid adrenocortical carcinoma: a clinicopathological and immunohistochemical study of three cases. Histopathology 62(5):771-7, 2013. e-Pub 2013. PMID: 23445527.
124. Benveniste MF, Moran CA, Mawlawi O, Fox PS, Swisher SG, Munden RF, Marom EM. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies. J Thorac Oncol 8(4):502-10, 2013. PMID: 23446204.
125. Rao N, Colby TV, Falconieri G, Cohen H, Moran CA, Suster S. Intrapulmonary solitary fibrous tumors: clinicopathologic and immunohistochemical study of 24 cases. Am J Surg Pathol 37(2):155-66, 2013. PMID: 23108019.
126. Weissferdt A, Moran CA. Staging of primary mediastinal tumors. Adv Anat Pathol 20(1):1-9, 2013. PMID: 23232566.
127. Kalemkerian GP, Akerley W, Bogner P, Borghaei H, Chow LQ, Downey RJ, Gandhi L, Ganti AK, Govindan R, Grecula JC, Hayman J, Heist RS, Horn L, Jahan T, Koczywas M, Loo BW, Merritt RE, Moran CA, Niell HB, O'Malley J, Patel JD, Ready N, Rudin CM, Williams CC, Gregory K, Hughes M, National Comprehensive Cancer Network. Small cell lung cancer. J Natl Compr Canc Netw 11(1):78-98, 2013. PMID: 23307984.
128. Guajardo-Salinas GE, Anaya-Ayala JE, Rice DC, Moran CA, Reardon MJ. Primary high-grade neuroendocrine carcinoma of the heart. Tex Heart Inst J 40(1):71-4, 2013. PMID: 23466749.
129. Vila Duckworth L, Winter WE, Vaysberg M, Moran CA, Al-Quran SZ. Intrathyroidal parathyroid carcinoma: report of an unusual case and review of the literature. Case Rep Pathol 2013:198643, 2013. e-Pub 2013. PMID: 23936709.
130. Weissferdt A, Moran CA. Primary pulmonary primitive neuroectodermal tumor (PNET): a clinicopathological and immunohistochemical study of six cases. Lung 190(6):677-83, 2012. e-Pub 2012. PMID: 22802134.
131. Fujimoto J, Kadara H, Garcia MM, Kabbout M, Behrens C, Liu DD, Lee JJ, Solis LM, Kim ES, Kalhor N, Moran CA, Sharafkhaneh A, Lotan R, Wistuba II. G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer. J Thorac Oncol 7(12):1747-54, 2012. PMID: 23154545.
132. Weissferdt A, Moran CA. Thymic hyperplasia with lymphoepithelial sialadenitis (LESA)-like features: a clinicopathologic and immunohistochemical study of 4 cases. Am J Clin Pathol 138(6):816-22, 2012. PMID: 23161715.
133. Weissferdt A, Moran CA. Thymomas with prominent signet ring cell-like features: a clinicopathologic and immunohistochemical study of 10 cases. Hum Pathol 43(11):1881-6, 2012. e-Pub 2012. PMID: 22575262.
134. Weissferdt A, Wistuba II, Moran CA. Molecular aspects of thymic carcinoma. Lung Cancer 78(2):127-32, 2012. e-Pub 2012. PMID: 22921473.
135. Kalhor N, Moran CA. Thymoma: current concepts. Oncology (Williston Park) 26(10):975-81, 2012. PMID: 23176011.
136. Weissferdt A, Lin H, Woods D, Tang X, Fujimoto J, Wistuba II, Moran CA. HER family receptor and ligand status in thymic carcinoma. Lung Cancer 77(3):515-21, 2012. e-Pub 2012. PMID: 22726920.
137. Grosu HB, Jimenez CA, Eapen GA, Ost D, Moran CA, Morice RC. The iron lady. Am J Respir Crit Care Med 186(5):460, 2012. PMID: 22942346.
138. Tsuta K, Wistuba II, Moran CA. Differential expression of somatostatin receptors 1-5 in neuroendocrine carcinoma of the lung. Pathol Res Pract 208(8):470-4, 2012. e-Pub 2012. PMID: 22770972.
139. Weissferdt A, Moran CA. Micronodular thymic carcinoma with lymphoid hyperplasia: a clinicopathological and immunohistochemical study of five cases. Mod Pathol 25(7):993-9, 2012. e-Pub 2012. PMID: 22388764.
140. Neary NM, Lopez-Chavez A, Abel BS, Boyce AM, Schaub N, Kwong K, Stratakis CA, Moran CA, Giaccone G, Nieman LK. Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years. J Clin Endocrinol Metab 97(7):2223-30, 2012. e-Pub 2012. PMID: 22508705.
141. Weissferdt A, Moran CA. Thymic carcinoma, part 1: a clinicopathologic and immunohistochemical study of 65 cases. Am J Clin Pathol 138(1):103-14, 2012. PMID: 22706865.
142. Weissferdt A, Moran CA. Thymic carcinoma, part 2: a clinicopathologic correlation of 33 cases with a proposed staging system. Am J Clin Pathol 138(1):115-21, 2012. PMID: 22706866.
143. Weissferdt A, Moran CA. Anaplastic thymic carcinoma: a clinicopathologic and immunohistochemical study of 6 cases. Hum Pathol 43(6):874-7, 2012. e-Pub 2011. PMID: 22055398.
144. Solis LM, Behrens C, Raso MG, Lin HY, Kadara H, Yuan P, Galindo H, Tang X, Lee JJ, Kalhor N, Wistuba II, Moran CA. Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer 118(11):2889-99, 2012. e-Pub 2011. PMID: 22020674.
145. Weissferdt A, Suster S, Moran CA. Primary Mediastinal "Thymic" Seminomas. Adv Anat Pathol 19(2):75-80, 2012. PMID: 22313835.
146. Moran CA, Weissferdt A, Kalhor N, Solis LM, Behrens C, Wistuba II, Suster S. Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema. Am J Clin Pathol 137(3):444-50, 2012. PMID: 22338057.
147. Moran CA, Walsh G, Suster S, Kaiser L. Thymomas II: a clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment. Am J Clin Pathol 137(3):451-61, 2012. PMID: 22338058.
148. Weissferdt A, Moran CA. Primary MALT-type lymphoma of the thymus: a clinicopathological and immunohistochemical study of six cases. Lung 189(6):461-6, 2011. e-Pub 2011. PMID: 21989494.
149. Benveniste MF, Rosado-de-Christenson ML, Sabloff BS, Moran CA, Swisher SG, Marom EM. Role of imaging in the diagnosis, staging, and treatment of thymoma. Radiographics 31(7):1847-61; discussion 1861-3, 2011. PMID: 22084174.
150. Weissferdt A, Moran CA. Pulmonary salivary gland-type tumors with features of malignant mixed tumor (carcinoma ex pleomorphic adenoma): a clinicopathologic study of five cases. Am J Clin Pathol 136(5):793-8, 2011. PMID: 22031319.
151. Kalhor N, Suster S, Moran CA. Primary pulmonary chondrosarcomas: a clinicopathologic study of 4 cases. Hum Pathol 42(11):1629-34, 2011. e-Pub 2011. PMID: 21496864.
152. Glisson BS, Moran CA. Large-cell neuroendocrine carcinoma: controversies in diagnosis and treatment. J Natl Compr Canc Netw 9(10):1122-9, 2011. PMID: 21975912.
153. Kalemkerian GP, Akerley W, Bogner P, Borghaei H, Chow L, Downey RJ, Gandhi L, Ganti AK, Govindan R, Grecula JC, Hayman J, Heist RS, Horn L, Jahan TM, Koczywas M, Moran CA, Niell HB, O'Malley J, Patel JD, Ready N, Rudin CM, Williams CC. Small cell lung cancer. J Natl Compr Canc Netw 9(10):1086-113, 2011. PMID: 21975911.
154. Tsuta K, Kalhor N, Wistuba II, Moran CA. Clinicopathological and immunohistochemical analysis of spindle-cell carcinoid tumour of the lung. Histopathology 59(3):526-36, 2011. PMID: 22034892.
155. Weissferdt A, Moran CA. Microcystic squamous cell carcinoma of the lung: a clinicopathologic study of three cases. Am J Clin Pathol 136(3):436-41, 2011. PMID: 21846920.
156. Weissferdt A, Moran CA. Pax8 expression in thymic epithelial neoplasms: an immunohistochemical analysis. Am J Surg Pathol 35(9):1305-10, 2011. PMID: 21836478.
157. Xie Y, Xiao G, Coombes KR, Behrens C, Solis LM, Raso G, Girard L, Erickson HS, Roth J, Heymach JV, Moran CA, Danenberg K, Minna JD, Wistuba II. Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients. Clin Cancer Res 17(17):5705-14, 2011. e-Pub 2011. PMID: 21742808.
158. Tsuta K, Liu DC, Kalhor N, Wistuba II, Moran CA. Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas. Am J Clin Pathol 136(2):252-9, 2011. PMID: 21757598.
159. Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 6(7):1274-81, 2011. PMID: 21623235.
160. Weissferdt A, Moran CA. Thymic carcinoma associated with multilocular thymic cyst: a clinicopathologic study of 7 cases. Am J Surg Pathol 35(7):1074-9, 2011. PMID: 21677542.
161. Detterbeck FC, Moran CA, Huang J, Suster S, Walsh G, Kaiser L, Wick M. Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol 6(7 Suppl 3):S1730-8, 2011. PMID: 21847055.
162. Detterbeck FC, Nicholson AG, Kondo K, Van Schil P, Moran CA. The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms. J Thorac Oncol 6(7 Suppl 3):S1710-6, 2011. PMID: 21847052.
163. Moran CA. Importance of molecular features of non-small cell lung cancer for choice of treatment. Am J Pathol 178(5):1940-8, 2011. PMID: 21514411.
164. Weissferdt A, Moran CA. Malignant biphasic tumors of the lungs. Adv Anat Pathol 18(3):179-89, 2011. PMID: 21490435.
165. Tsuta K, Kalhor N, Raso MG, Wistuba II, Moran CA. Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases. Hum Pathol 42(4):578-85, 2011. PMID: 21329962.
166. Tang X, Kadara H, Behrens C, Liu DD, Xiao Y, Rice D, Gazdar AF, Fujimoto J, Moran CA, Varella-Garcia M, Lee JJ, Hong WK, Wistuba II. Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis. Clin Cancer Res 17(8):2434-43, 2011. e-Pub 2011. PMID: 21257719.
167. Kalhor N, Suster S, Moran CA. Spindle cell thymomas (WHO Type A) with prominent papillary and pseudopapillary features: a clinicopathologic and immunohistochemical study of 10 cases. Am J Surg Pathol 35(3):372-7, 2011. PMID: 21317709.
168. Tsuta K, Raso MG, Kalhor N, Liu DD, Wistuba II, Moran CA. Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung. Lung Cancer 71(1), 2011. PMID: 20462655.
169. Tsuta K, Raso MG, Kalhor N, Liu DC, Wistuba II, Moran CA. Sox10-positive sustentacular cells in neuroendocrine carcinoma of the lung. Histopathology 58(2):276-85, 2011. PMID: 21323953.
170. Weissferdt A, Hernandez JC, Kalhor N, Moran CA. Spindle Cell Thymomas: An Immunohistochemical Study of 30 Cases. Appl Immunohistochem Mol Morphol 19(4):329-35, 2011. PMID: 21386704.
171. Alousi A, Ghosh S, Rice D, Moran CA, Manning JT, Iliescu C, Hymes S, Kim S, Bashoura L, Kornblau S, Dickey BF. Pleuropericarditis, obliterative bronchiolitis and lymphocytic interstitial pneumonitis after allogeneic haematopoietic stem cell transplantation. BMJ Case Rep 2011, 2011. e-Pub 2011. PMID: 22707568.
172. Weissferdt A, Kalhor N, Suster S, Moran CA. Primary angiosarcomas of the anterior mediastinum: a clinicopathologic and immunohistochemical study of 9 cases. Hum Pathol 41(12):1711-7, 2010. PMID: 20709359.
173. Moran CA, Kalhor N, Suster S. Invasive spindle cell thymomas (WHO Type A): a clinicopathologic correlation of 41 cases. Am J Clin Pathol 134(5):793-8, 2010. PMID: 20959663.
174. Weissferdt A, Kalhor N, Suster S, Moran CA. Adenomatoid spindle cell thymomas: a clinicopathological and immunohistochemical study of 20 cases. Am J Surg Pathol 34(10):1544-9, 2010. PMID: 20852406.
175. Weissferdt A, Moran CA. Primary vascular tumors of the lungs: a review. Ann Diagn Pathol 14(4):296-308, 2010. e-Pub 2010. PMID: 20637438.
176. Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC, Moran CA, Corvalan AH, Biswal S, Swisher SG, Bekele BN, Minna JD, Stewart DJ, Wistuba II. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res 16(14):3743-53, 2010. e-Pub 2010. PMID: 20534738.
177. Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J, Moran CA, Vaporciyan AA, Roth JA. Non-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg 90(1):210-6, 2010. PMID: 20609777.
178. Kalhor N, Marom EM, Moran CA. Primary myxoma of the lung. Ann Diagn Pathol 14(3):178-81, 2010. PMID: 20471563.
179. Contreras AL, Punar M, Tamboli P, Tu SM, Pisters L, Moran CA, Czerniak BA, Guo CC. Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases. Hum Pathol 41(6):832-7, 2010. e-Pub 2010. PMID: 20153508.
180. Kalhor N, Suster S, Moran CA. Primary sclerosing neuroendocrine carcinomas of the lung: A clinicopathologic and immunohistochemical study of 10 cases. Am J Clin Pathol 133(4):618-22, 2010. PMID: 20231615.
181. Morkowski JJ, Nguyen CV, Lin P, Farr M, Abraham SC, Gilcrease MZ, Moran CA, Wu Y. Rosai-Dorfman disease confined to the breast. Ann Diagn Pathol 14(2):81-7, 2010. PMID: 20227012.
182. Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, Gönen M, Jensen RT, Kidd M, Kulke MH, Lloyd RV, Moran CA, Moss SF, Oberg K, O'Toole D, Rindi G, Robert ME, Suster S, Tang LH, Tzen CY, Washington MK, Wiedenmann B, Yao J. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol 34(3):300-13, 2010. PMID: 20118772.
183. Kalhor N, Staerkel GA, Moran CA. So-called sclerosing hemangioma of lung: current concept. Ann Diagn Pathol 14(1):60-7, 2010. PMID: 20123460.
184. Solis LM, Raso MG, Kalhor N, Behrens C, Wistuba II, Moran CA. Primary oncocytic adenocarcinomas of the lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases. Am J Clin Pathol 133(1):133-40, 2010. PMID: 20023269.
185. Nagarjun Rao R, Moran CA, Suster S. Histiocytic disorders of the lung. Adv Anat Pathol 17(1):12-22, 2010. PMID: 20032634.
186. Yuan P, Kadara H, Behrens C, Tang X, Woods D, Solis LM, Huang J, Spinola M, Dong W, Yin G, Fujimoto J, Kim E, Xie Y, Girard L, Moran CA, Hong WK, Minna JD, Wistuba II. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. PLoS One 5(2):e9112, 2010. e-Pub 2010. PMID: 20161759.
187. Kalhor N, Moran CA. Primary Mediastinal Neuroendocrine Tumors. Diagnostic Histopathology 16(5):237-242, 2010.
188. Suster S, Moran CA. Problems in the classification of thymomas. Diagnostic Histopathology 16(5):221-308, 2010.
189. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418.e1-2, 2009. e-Pub 2009. PMID: 19619787.
190. Raso MG, Behrens C, Herynk MH, Liu S, Prudkin L, Ozburn NC, Woods DM, Tang X, Mehran RJ, Moran CA, Lee JJ, Wistuba II. Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation. Clin Cancer Res 15(7):5359-69, 2009. PMID: 19706809.
191. Nguyen CV, Suster S, Moran CA. Pulmonary epithelial-myoepithelial carcinoma: a clinicopathologic and immunohistochemical study of 5 cases. Hum Pathol 40(3):366-73, 2009. PMID: 18973918.
192. Blackmon SH, Rice DC, Correa AM, Mehran R, Putnam JB, Smythe WR, Walkes JC, Walsh GL, Moran CA, Singh H, Vaporciyan AA, Reardon M. Management of primary pulmonary artery sarcomas. Ann Thorac Surg 87(3):977-84, 2009. PMID: 19231448.
193. Prudkin L, Liu DD, Ozburn NC, Sun M, Behrens C, Tang X, Brown KC, Bekele BN, Moran CA, Wistuba II. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol 22(5):668-78. e-Pub 2009. PMID: 19270647.
194. Moran CA, Suster S. Neuroendocrine tumors of the lung; review of classification and pitfalls in diagnosis. Adv Anat Pathol 131(2):206-21, 2009.
195. Moran CA, Suster S. The World Health Organization (WHO) histologic classification of thymomas: a reanalysis. Curr Treat Options Oncol 9(4-6):288-99, 2009. PMID: 19191029.
196. Moran CA, Suster S, Coppola D, Wick MR. Neuroendocrine carcinomas of the lung: a critical analysis. Am J Clin Pathol 131(2):206-21, 2009. PMID: 19141381.
197. Arrosi VA, Rice D, Moran CA. Mesotheliomas: a clinicopathological and immunohiosthcemical study of 57 cases treated with extrapleural pneumonectomy. Am J Clin Pathol 130(5), 2009.
198. Arrossi AV, Lin E, Rice D, Moran CA. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy. Am J Clin Pathol 130(5):754-64, 2008. PMID: 18854268.
199. Tang X, Varella-Garcia M, Xavier AC, Massarelli E, Ozburn N, Moran CA, Wistuba II. Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas. Cancer Prev Res (Phila Pa) 1(3):192-200, 2008. PMID: 19138956.
200. Gupta R, Marchevsky AM, McKenna RJ, Wick M, Moran CA, Zakowski MF, Suster S. Evidence-based pathology and the pathologic evaluation of thymomas: transcapsular invasion is not a significant prognostic feature. Arch Pathol Lab Med 132(6):926-930, 2008. PMID: 18517274.
201. Suster S, Moran CA. Histologic classification of thymoma: the World Health Organization and beyond. Hematol Oncol Clin North Am 22(3):381-92, 2008. PMID: 18514122.
202. Moran CA, Suster S. Thymic carcinoma: current concepts and histologic features. Hematol Oncol Clin North Am 22(3):393-407, 2008. PMID: 18514123.
203. Moran CA, Albores-Saavedra J, Suster S. Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases. Histopathology 52(7):824-30, 2008. PMID: 18494612.
204. Marchevsky AM, Gupta R, McKenna RJ, Wick M, Moran CA, Zakowski MF, Suster S. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 112(12):2780-8, 2008. PMID: 18442102.
205. Prudkin L, Behrens C, Liu DD, Zhou X, Ozburn NC, Bekele BN, Minna JD, Moran CA, Rogh JA, Ji L, Wistuba II. Loss and reduction of Fus 1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer. Clin Cancer Res 14(1):41-47, 2008. PMID: 18172250.
206. Edelweiss M, Medeiros LJ, Suster S, Moran CA. Lymph node involvement by Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical study of 20 cases. Hum Pathol 38(10):1463-9, 2007. e-Pub 2007. PMID: 17669469.
207. Huang EH, Liao Z, Cox JD, Guerrero TM, Chang JY, Jeter M, Borghero Y, Wei X, Fossella F, Herbst RS, Blumenschein GR, Moran C, Allen PK, Komaki R. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone. Int J Radiat Oncol Biol Phys 68(3):779-85, 2007. PMID: 17418967.
208. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid, atypical carcinoid, small cell carcinoma, and large cell neuroendocrine carcinoma): current concepts. Hematol Oncol Clin North Am 21(3):395-407; vii, 2007. PMID: 17548031.
209. Bruzzi JF, Truong MT, Gladish GW, Wallace MJ, Moran CA, Munden RF. Development of pulmonary arteriovenous communications within pulmonary metastases after chemotherapy. Journal of Thoracic Oncology 2(3):243-6, 2007. PMID: 17410048.
210. Moran CA, Suster S. Unusual non-neoplastic lesions of the lung. Semin Diagn Pathol 24(3):199-208, 2007. PMID: 17882903.
211. Moran CA, Suster S. Neuroendocrine carcinomas of the lung; current concepts. Hematology/Oncology Clinics of North America 21(3):395-407, 2007.
212. Dominguez H, Moran CA, Suster S. Mediastinal germ cell tumors with sarcomatous compnent: A clinicopathologic and immunohistochemical study of 46 cases. Am J Surg Pathol 31(9):1356-1362, 2007.
213. Suster S, Moran CA. Diffuse pulomonary meningotheliomatosis. Am J Surg Pathol 31(4):624-631, 2007.
214. Suster S, Moran CA. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Adv Anat Pathol 13(6):316-29, 2006. PMID: 17075297.
215. Moran CA, Suster S. Cystic well-differentiated neuroendocrine carcinoma (carcinoid tumor): a clinicopathologic and immunohistochemical study of two cases. Am J Clin Pathol 126(3):377-80, 2006. PMID: 16880146.
216. Ren R, Guo M, Sneige N, Moran CA, Gong Y. Fine-needle aspiration of adrenal cortical carcinoma: cytologic spectrum and diagnostic challenges. Am J Clin Pathol 126(3):389-98, 2006. PMID: 16880150.
217. Moran CA. Pulmonary adenocarcinoma: the expanding spectrum of histologic variants. Arch Pathol Lab Med 130(7):958-62, 2006. PMID: 16831050.
218. Allen TC, Moran CA. Synchronous pulmonary carcinoma and pleural diffuse malignant mesothelioma. Arch Pathol Lab Med 130(5):721-4, 2006. PMID: 16683892.
219. Huo L, Moran CA, Fuller GN, Gladish G, Suster S. Pulmonary artery sarcoma: a clinicopathologic and immunohistochemical study of 12 cases. Am J Clin Pathol 125(3):419-24, 2006. PMID: 16613346.
220. Gong Y, Sneige N, Guo M, Hicks ME, Moran CA. Transthoracic fine-needle aspiration vs concurrent core needle biopsy in diagnosis of intrathoracic lesions: a retrospective comparison of diagnostic accuracy. Am J Clin Pathol 125(3):438-44, 2006. PMID: 16613349.
221. Jian L, Admirand JH, Moran CA, Ford RJ, Bueso-Ramos CD. Medistinal follicular dendritic cell sarcoma involving bone marrow. Am Diag Pathol 10:357-362, 2006.
222. Seethala R, Moran CA. Angiomatoid fibrous histiocytoma of the mediatinum. Pathology Case Reviews 11(5):222-225, 2006.
223. Moran CA, Suster S. The spectrum of neuroendocrine tumors of the mediastinum. Pathology Case Reviews 11(5):199-205, 2006.
224. Suster S, Moran CA. Thymoma classification: current status and future trends. Am J Clin Pathol 125(4):542-554, 2006. PMID: 16627265.
225. Plaza JA, Wakely PE, Moran CA, Fletcher CD, Suster S. Sclerosing paraganglioma: report of 19 cases of an unusual variant of neuroendocrine tumor that may be mistaken for an aggressive malignant neoplasm. Am J Surg Pathol 30(1):7-12, 2006. PMID: 16330936.
226. Moran CA, Suster S. Primary parathyroid tumors of the mediastinum: a clinicopathologic and immunohistochemical study of 17 cases. Am J Clin Pathol 124(5):749-54, 2005. PMID: 16203274.
227. Suster S, Moran CA. Malignant mesothelioma: current status of histopathologic diagnosis and molecular profile. Expert Rev Mol Diagn 5(5):715-23, 2005. PMID: 16149874.
228. Steinhauer JR, Moran CA, Suster S. Secretory endometrioid-like' adenocarcinoma of the lung. Histopathology 47(2):219-20, 2005. PMID: 16045787.
229. Suster S, Moran CA. Problem areas and inconsistencies in the WHO classification of thymoma. Semin Diagn Pathol 22:188-97, 2005. PMID: 16711400.
230. Huo L, Lai S, Gladish G, Czerniak BA, Moran CA. Pulmonary artery angiosarcoma: a clinicopathologic and radiological correlation. Ann Diagn Pathol 9(4):209-14, 2005. PMID: 16084454.
231. Moran CA. Primary neuroendocrine carcinomas of the mediastinum: review of current criteria for histopathologic diagnosis and classification. Semin Diagn Pathol 22(3):223-9, 2005. PMID: 16711403.
232. Moran CA, Suster S. Angiolymphoid hyperplasia with eosinophilia (epithelioid hemangioma) of the lung: a clinicopathologic and immunohistochemical study of two cases. Am J Clin Pathol 123(5):762-5, 2005. PMID: 15981816.
233. Suster S, Moran CA. Primary synovial sarcomas of the mediastinum: a clinicopathologic, immunohistochemical, and ultrastructural study of 15 cases. Am J Surg Pathol 29:569-78, 2005. PMID: 15832079.
234. Moran CA, Suster S, Silva EG. Low-grade serous carcinoma of the ovary metastatic to the anterior mediastinum simulating multilocular thymic cysts: a clinicopathologic and immunohistochemical study of 3 cases. Am J Surg Pathol 29(4):496-9, 2005. PMID: 15767804.
235. Nicolas M, Moran CA, Suster S. Pulmonary metastasis from liposarcoma: a clinicopathologic and immunohistochemical study of 24 cases. Am J Clin Pathol 123(2):265-75, 2005. PMID: 15842053.
236. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam JB, Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23(6):1136-43, 2005. PMID: 15718309.
237. Abrahams NA, Moran CA, Reyes AO, Siefker-Radtke A, Ayala AG. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases. Histopathology 46(1):57-63, 2005. PMID: 15656887.
238. Reyes A, Moran CA. Low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate. Arch Pathol Lab Med 128(12):e166-8, 2004. PMID: 15578903.
239. de Queiroga EM, Chikota H, Bacchi CE, Moran CA, Suster S. Rhabdomyomatous carcinoma of the thymus. Am J Surg Pathol 28(9):1245-50, 2004. PMID: 15316327.
240. Siefker-Radtke AO, Dinney CP, Abrahams NA, Moran CA, Shen Y, Pisters LL, Grossman HB, Swanson DA, Millikan RE. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J Urol 172(2):481-4, 2004. PMID: 15247709.
241. Moran CA, Jagirdar J, Suster S. Papillary lung carcinoma with prominent "morular" component. Am J Clin Pathol 122(1):106-9, 2004. PMID: 15272538.
242. Moran CA, Suster S. "Ancient" (sclerosing) thymomas: a clinicopathologic study of 10 cases. Am J Clin Pathol 121(6):867-71, 2004. PMID: 15198359.
243. Marom EM, Moran CA, Munden RF. Generalized lymphangiomatosis. AJR Am J Roentgenol 182(4):1068, 2004. PMID: 15039189.
244. Moran CA, Suster S, El-Naggar A, Luna MA. Carcinomas arising in multilocular thymic cysts of the neck: a clinicopathological study of three cases. Histopathology 44(1):64-8, 2004. PMID: 14717671.
245. Khoury JD, Shephard MN, Moran CA. Cystic sclerosing haemangioma of the lung. Histopathology 43(3):239-43, 2003. PMID: 12940776.
246. Moran CA, Suster S. Primary mucoepidermoid carcinoma of the pleura. A clinicopathologic study of two cases. Am J Clin Pathol 120:381-5, 2003. PMID: 14502801.
247. Reyes A, Moran CA, Suster S, Michal M, Dominguez H. Neuroendocrine carcinomas (carcinoid tumor) of the testis. A clinicopathologic and immunohistochemical study of ten cases. Am J Clin Pathol 120:182-7, 2003. PMID: 12931547.
248. Marchevsky, Hammond ME, Moran CA, Suster S:. Protocol for the examination of specimens from patients with thymic epithelial tumors located in any area of the mediastinum. Arch Pathol Lab Med 127(10):1298-1303, 2003. PMID: 14521466.
249. Sasaki, Komaki R, Macapinlac H, Erasmus J, Allen P, Foster K, Roth J, Putnam JB, Moran CA, Cox JD. SUV by FDG-PET predicts outcome of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1((2 suppl)):57, 2003. PMID: 15718309.
250. Conner MG, Richter H, Moran CA, Hameed A, Albores-Saavedra J. Small cell carcinoma of the cervix: a clinicopathologic and immunohistochemical study of 23 cases. Ann Diagn Pathol 6(6):345-8, 2002. PMID: 12478483.
251. Malpica A, Moran CA. Primitive neuroectodermal tumor of the cervix: a clinicopathologic and immunohistochemical study of two cases. Ann Diagn Pathol 6(5):281-7, 2002. PMID: 12376920.
252. Chhieng DC, Lin O, Moran CA, Eltoum IA, Jhala NC, Jhala DN, Simsir A. Fine-needle aspiration biopsy of nonteratomatous germ cell tumors of the mediastinum. Am J Clin Pathol 118(3):418-24, 2002. PMID: 12219784.
253. Fu K, Moran CA, Suster S. Primary mediastinal giant cell tumors: a clinicopathologic and immunohistochemical study of two cases. Ann Diagn Pathol 6(2):100-5, 2002. PMID: 12004357.
254. Castro CY, Moran CA, Flieder DG, Suster S. Primary signet ring cell adenocarcinomas of the lung: a clinicopathological study of 15 cases. Histopathology 39(4):397-401, 2001. PMID: 11683941.
255. Adams AL, Castro CY, Singh SP, Moran CA. Pleural amyloidosis mimicking mesothelioma: a clinicopathologic study of two cases. Ann Diagn Pathol 5(4):229-32, 2001. PMID: 11510005.
256. Moran CA, Suster S. Thymoma with prominent cystic and hemorrhagic changes and areas of necrosis and infarction: a clinicopathologic study of 25 cases. Am J Surg Pathol 25(8):1086-90, 2001. PMID: 11474295.
257. Wick MR, Moran CA, Mills SE, Suster S. Immunohistochemical differential diagnosis of pleural effusions, with emphasis on malignant mesothelioma. Curr Opin Pulm Med 7(4):187-92, 2001. PMID: 11470972.
258. Moran CA, Suster S, Abbondanzo SL. Cutaneous B-cell lymphoma with signet ring-cell morphology: a clinicopathologic and immunohistochemical study of three cases. Am J Dermatopathol 23(3):181-4, 2001. PMID: 11391096.
259. Steinhauer JR, Moran CA, Siegal GP. Pathologic quiz case: an asymptomatic patient with large renal mass. Arch Pathol Lab Med 125(6):828-30, 2001. PMID: 11371243.
260. Kraus MD, Haley JC, Ruiz R, Essary L, Moran CA, Fletcher CD. "Juvenile" xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis. Am J Dermatopathol 23(2):104-11, 2001. PMID: 11285404.
261. Moran CA Suster S. Neuroendocrine carcinomas of the thymus. Pathology Case Reviews 6(2):41-47, 2001.
262. Moran CA, Suster S. Neuroendocrine neoplasms of the mediastinum. Am J Clin Pathol 115:S17-S27, 2001. PMID: 11993687.
263. Moran CA, Suster S. On the histologic heterogeneity of thymic epithelial neoplasms. Impact of sampling in subtyping and classification of thymomas. Am J Clin Pathol 114:760-6, 2000. PMID: 11068551.
264. Moran CA, Wick MR, Suster S. The role of immunohistochemistry in the diagnosis of malignant mesothelioma. Semin Diagn Pathol 17:178-83, 2000. PMID: 10968703.
265. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 114:100-10, 2000. PMID: 10884805.
266. Moran CA, Suster S. Primary neuroendocrine carcinoma (thymic carcinoid) of the thymus with prominent oncocytic features: a clinicopathologic study of 22 cases. Mod Pathol 13:489-94, 2000. PMID: 10824919.
267. Moran CA, Suster S. Thymic neuroendocrine carcinomas with combined features ranging from well-differentiated (carcinoid) to small cell carcinoma. A clinicopathologic and immunohistochemical study of 11 cases. Am J Clin Pathol 113(3):345-50, 2000. PMID: 10705813.